NIF

(redirected from S100A8)
Also found in: Medical, Financial.

NIF

(communications)
References in periodicals archive ?
Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis.
Moreover, S100A8 (calgranulin A) and S100A9 (calgranulin B) both relate to ROS production.
The production of S100A8 is elevated in cytotrophoblasts, placental-tissue macrophages, fibroblast-like cells, endothelial cells, and monocytic lineages.
Calprotectin is a calcium and zinc binding protein complex formed by S100A8 and S100A9 proteins.
Other calcium ion binding proteins include calmodulin or S100A8 and S100A9, which complex to form calprotectin, which explains almost identical localization in Figure 5, a through e and f through j.
23), (24) Furthermore, a significant correlation has been found between high concentrations of serum S100A8 /A9 and SLE disease activity, suggesting that it can be used as a reliable test of infection in SLE patients.
Role of S100A8 and S100A9 in Neutrophil recruitment in response to monosodium urate monohydrate in the air-pouch model of acute gouty arthritis.
The mass restricted score includes four proteomic biomarkers: defensin-2, defensin-1, S100A12, and S100A8 proteins.
Finally, the authors identified and validated a triad of limited proteomic biomarkers that can separate VAP [sup]+ from VAP [sup]− patients: S100A8, lactotransferrin, and actinin 1.
S100A8 and S100A9 calcium-binding proteins: localization within normal and cyclosporin A-induced overgrowth gingiva.